BelHealth Investment Partners, a healthcare private equity firm has announced the sale of VFP Pharmacy Group (VFP), one of the largest independent national fertility pharmacies in the United States. The buyer and terms of the transaction were not disclosed.
BelHealth acquired VFP in August 2015 and has since grown revenues more than fivefold, driven primarily by securing large institutional contracts with prominent fertility payors and clinics across the country according to the firm.
Harold S. Blue, Founding Partner of BelHealth commented: “BelHealth identified an early opportunity to build a pre-eminent national fertility pharmacy to capitalize on favorable demographic and reimbursement trends in women’s health, and I am proud of what the team accomplished.”
Inder Tallur, Partner at BelHealth added: “Hiring an outstanding management team led by Rich Burkett to develop the platform was a pivotal point in the life cycle of our investment. The team built strong partnerships with leading players in the fertility sector, who recognized VFP’s strengths, leading to the company’s growth over the years.”
VFP Pharmacy Group is a network of specialty fertility pharmacies that provide exceptional service and educational resources to fertility patients and clinics nationwide. Licensed in all 50 states, VFP includes Village Fertility Pharmacy locations in Boston and Chicago, as well as Integrity Rx in Phoenix.
BelHealth Investment Partners focuses on lower middle market healthcare companies, acquiring majority positions in entrepreneur-owned businesses that can benefit from the firm’s extensive investing, executive management, and entrepreneurial experience. BelHealth is currently investing from its $350 million fund.
